Ibnsina Pharma

CAI:ISPH (Egypt)   Ordinary Shares
E£ 2.60 (-1.89%) Jun 6
15.47
P/B:
1.70
Market Cap:
E£ 2.62B ($ 55.17M)
Enterprise V:
E£ 6.75B ($ 142.08M)
Volume:
4.04M
Avg Vol (2M):
12.93M
Volume:
4.04M
Avg Vol (2M):
12.93M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Ibnsina Pharma ( ) from 2017 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ibnsina Pharma stock (CAI:ISPH) PE ratio as of Jun 07 2024 is 15.47. More Details

Ibnsina Pharma (CAI:ISPH) PE Ratio (TTM) Chart

To

Ibnsina Pharma (CAI:ISPH) PE Ratio (TTM) Historical Data

Total 1283
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Ibnsina Pharma PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-07 15.5 2024-04-07 15.1
2024-06-06 15.5 2024-04-04 14.9
2024-06-05 15.8 2024-04-03 14.7
2024-06-04 16.2 2024-04-02 14.6
2024-06-03 16.4 2024-04-01 14.9
2024-06-02 15.5 2024-03-31 14.2
2024-05-30 15.6 2024-03-28 15.2
2024-05-29 15.7 2024-03-27 18.2
2024-05-28 15.7 2024-03-26 18.7
2024-05-27 15.8 2024-03-25 19.1
2024-05-26 15.5 2024-03-24 18.2
2024-05-23 15.5 2024-03-21 18.0
2024-05-22 15.1 2024-03-20 17.3
2024-05-21 15.2 2024-03-19 17.6
2024-05-20 14.6 2024-03-18 18.0
2024-05-19 14.7 2024-03-17 19.7
2024-05-16 14.1 2024-03-14 19.8
2024-05-15 13.3 2024-03-13 19.3
2024-05-14 13.3 2024-03-12 20.3
2024-05-13 13.6 2024-03-11 21.3
2024-05-12 13.3 2024-03-10 22.0
2024-05-09 14.4 2024-03-07 22.0
2024-05-08 14.5 2024-03-06 23.0
2024-05-07 14.6 2024-03-05 25.1
2024-05-06 14.6 2024-03-04 24.9
2024-05-05 14.6 2024-03-03 24.7
2024-05-02 14.6 2024-02-29 25.7
2024-05-01 14.1 2024-02-28 24.3
2024-04-30 14.1 2024-02-27 24.7
2024-04-29 15.2 2024-02-26 25.7
2024-04-28 14.1 2024-02-25 25.9
2024-04-25 15.4 2024-02-22 27.0
2024-04-24 15.4 2024-02-21 26.7
2024-04-23 16.8 2024-02-20 27.4
2024-04-22 17.3 2024-02-19 25.7
2024-04-21 16.3 2024-02-18 27.4
2024-04-18 15.8 2024-02-15 27.4
2024-04-17 17.2 2024-02-14 25.8
2024-04-16 16.8 2024-02-13 25.7
2024-04-15 16.7 2024-02-12 23.0
2024-04-14 15.7 2024-02-11 22.9
2024-04-11 15.7 2024-02-08 23.2
2024-04-10 15.7 2024-02-07 22.0
2024-04-09 15.7 2024-02-06 23.1
2024-04-08 15.7 2024-02-05 23.4

Ibnsina Pharma (CAI:ISPH) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.